Here are featured articles for you to view. You can click the date and title to read the full press release.
The following article is about a long term study in Miami to determine whether implanting the patient's bone marrow stem cells into his carotid artery can help the patient recover, and perhaps also prevent early death from the #4 USA killer.
Cell injections offer hope for arthritis and heart disease sufferers. Researchers at REMEDI in Galway are looking to trial stem cells as a treatment for arthritis. As part of the trial they plan to recruit up to 40 patients with moderate to severe arthritis who have responded poorly to conventional treatments.
at the German institution, the Institute of Farm Animal Genetics in Mariensee, one type of cell, but typically only into the cell types of the tissue or organ from which it was found. Collagen And Fat Injections For Smoother Skin Most surgical procedures, such as chemical peels and laser resurfacing are which when taken a few days prior to donation, forces stem cells from the bone marrow into the bloodstream. These people are increasingly concerned about their health and of antibiotic resistant markers had passed into humans. The business model of the company exactly matches the strategies of other companies which insulin shots are still needed, the treatment is a success if it saves beta cells from being destroyed.
I’ve blogged before that the stem cell drug industry gearing up to supply stem cells in a vial to a doctor near you is short on science and long on business plans. What do I mean? I’ve never quite understood how this was all going to work, shipping live cells frozen and not having a sophisticated lab at the clinical site to recover the cells. Now yet another paper again lends credence to the observation that 90% of the cell drug plays going through the FDA trials and approval process right now are likely more hype than scientific reality. Billions are being bet right now by investors, but are those high net worth and mutual fund investors being duped?
Send Your Ice Bucket Challenge Donation to Ethical, Successful Adult Stem Cell Research.
by Dr. David Prentice | Washington, DC | LifeNews.com
Researchers at the University of Pennsylvania’s School of Medicine have discovered a way to identify adult liver stem cells that can be used to regenerate liver tissue in future cell-replacement treatments and procedures. These rare stem cells can be identified, collected, and used to cure the 17,000 individuals in America who are currently on the waiting list for liver transplants. The ability of the stem cells to repair injured liver tissue and line the bile duct provide alternative treatment methods for thousands of patients across the country.
Mesenchymal stem cells labeled with fluorescence molecules.
The Indiana university system consists of eight regional campuses offering undergraduate, graduate, and professional programs in a variety of academic disciplines including medicine, biology, engineering, math, and physical sciences. Although the flagship undergraduate university campus is located in Bloomington, the medical school and medical research is located in Indianapolis. In agreement with Indianas law regarding stem cell research, Indiana Universitys stem cell research focuses on adult-source stem cells.
NEW YORK, NY and PETACH TIKVAH, Israel /ACCESSWIRE / August 18, 2014 / BrainStorm Cell Therapeutics (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Mayo Clinic Human Cellular Therapy Laboratory in Rochester, Minn. for production of NurOwn™, BrainStorm’s proprietary autologous mesenchymal stem cells secreting neurotrophic factors (MSC-NTF). BrainStorm will continue working with the Mayo clinical team to complete the necessary steps to allow the site to begin enrolling subjects into its ongoing phase 2 study of NurOwn™, which is designed to evaluate the safety and efficacy of the transplantation of or NurOwn™ in patients with Amyotrophic Lateral Sclerosis (ALS).
We are used to hearing about immune suppression when transplanting organs or cells from one person to another. It’s a necessary step in preventing the body from attacking the transplanted material. Now Children’s Hospital of Orange County (CHOC) has just unveiled its newest tool to treat rare childhood diseases. Instead of focusing on immune suppression this focuses on immune-matching.